MGNX Stock Analysis: Buy, Sell, or Hold?
MGNX - MacroGenics, Inc.
$3.07
0.17 (5.86%)
▲
5d:
-3.46%
30d:
+47.6%
90d:
+90.68%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 12, 2026
Smart Money Accumulation
MGNX is down 5.5% this week, but smart money is accumulating calls. Top strike: $4 2026-05-15 with 2 OI. Call ratio: 100% View Scanner →
Strength: 7.7/10
Get Alerted When MGNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MGNX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: MGNX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: MGNX is currently trading at $3.07, which is considered slightly high relative to its 30-day fair value range of $2.16 to $3.17.
Technical Outlook: Technically, MGNX is in a strong uptrend. Immediate support is located at $2.71, while resistance sits at $3.26. The stock is showing strong short-term momentum, up 5.9% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $3.60 (+17.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MGNX is in a strong uptrend. Immediate support is located at $2.71, while resistance sits at $3.26. The stock is showing strong short-term momentum, up 5.9% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $3.60 (+17.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$2.16 -
$3.17
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.8%
All Signals
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.9%)
- BULLISH: Trading below Wall St target ($3.60)
Fair Price Analysis
30-Day Fair Range
$2.16 -
$3.17
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
±$0.42
(13.6%)
Support & Resistance Levels
Support Level
$2.71
Resistance Level
$3.26
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.16
Wall Street Target
$3.60
(+17.3%)
Revenue Growth (YoY)
113.0%
Earnings Growth (YoY)
-70.4%
Profit Margin
-49.9%
Share & Embed Analysis
Last updated: April 04, 2026 4:18 PM ET
Data refreshes hourly during market hours. Next update: 5:18 PM
Data refreshes hourly during market hours. Next update: 5:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MGNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$224 | 60 HOLD |
